Six years survival on imatinib with no disease progression after diagnosis of metastatic duodenal gastrointestinal stromal tumour: A case report
1 Department of General Surgery, George Eliot Hospital, College Street, Nuneaton, Warwickshire CV10 7DJ, UK
2 Department of General Surgery, Victoria Hospital, Whinney Heys Road, Blackpool, Lancashire FY3 8NR, UK
3 Institute of Clinical Sciences, Warwick Medical School, Coventry CV4 7AL, UK
Journal of Medical Case Reports 2008, 2:110 doi:10.1186/1752-1947-2-110Published: 18 April 2008
Additional file 1:
WHO scale for assessing the performance status of the patient. The table describes the WHO performance status in patients.
Format: JPEG Size: 48KB Download file
Additional file 2:
NICE guidelines on Imatinib therapy in GIST. The table describes the NICE guidelines for using Imatinib mesylate in GIST patients.
Format: JPEG Size: 78KB Download file